Bio
My scholarly research over the past 25 years has focused on understanding autistic symptoms in children with neurogenetic disorders such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome to determine how environmental and biological factors affect the development of these behaviors, toward the goal of creating patient-specific treatments. My investigations include state-of-the-art eye tracking, functional assessments of behavior under controlled experimental conditions, neuroimaging, and novel behavioral and pharmacological interventions. I am extensively trained in behavioral assessment and interventions, and provide clinical evaluations and consultation as a doctoral-level Board Certified Behavior Analyst (BCBA-D). Given that many children and families experience difficulties accessing in-person care, I am particularly interested in developing targeted treatments that can be delivered via telehealth.
